Megan Fox’s Ro Sparks advert explained: why she asked for less innuendo

Megan Fox is personifying an erectile dysfunction medication in Ro’s US advertising campaign, launched on October 1, 2026. The red-catsuit commercial introduces her partnership with Ro Sparks; Fox told PEOPLE she wanted humor to make the subject less embarrassing to discuss.

The twist: Fox said she expected to ask for a bolder concept, but the creators had already gone further with the innuendo than she wanted. Her response, she told PEOPLE, was: ‘Maybe we could dial it down a little bit.’

What Megan Fox says in the Ro Sparks advert

In the 30-second spot, Fox wears a fitted red catsuit and introduces herself as the product: ‘I’m Ro Sparks, a prescription medication for men.’ The performance mixes double meanings with descriptions of the advertised medication and its delivery, according to MediaPost’s account of the commercial.

‘If prescribed, I show up right at your door. Don’t worry, my packaging is very discreet,’ she says. That is the campaign’s central device: Fox speaks as the medication itself, making the product description part of the joke.

Why Fox agreed to the campaign

‘I personally feel like maybe I was born for this,’ Fox told PEOPLE in its exclusive interview. She said humor could help make conversations about erectile dysfunction less embarrassing, and spoke about intimacy difficulties affecting partners as well as the person experiencing them.

Fox also emphasised supportive, open conversation. Her explanation gives the campaign a stated purpose beyond the visual joke, but it remains her reason for participating: the interview does not establish that the advertisement has changed viewers’ attitudes or improved communication between partners.

Ro’s explanation centres on Fox’s public persona. Rahmanian called the approach ‘tongue-in-cheek’ and described her as ‘one of the culture’s most recognizable icons,’ with the ability to bring the subject into entertainment and social conversations.

He told MediaPost that featuring a woman was a deliberate choice, saying men ‘really listen and lean in when a woman is part of the conversation.’ That is Ro’s marketing rationale, offered by its co-founder, rather than an independently tested finding about this campaign’s audience.

Where the Megan Fox campaign will appear

MediaPost reported a launch across Paramount+ and Peacock streaming, paid social and linear television. Rahmanian described it as Ro’s largest erectile dysfunction campaign, although the report did not disclose a spending figure. The distribution plan explains where the company is buying visibility.

Rahmanian outlined four television versions over the following two months, with advertising purchases including ESPN and college football programming. He also described ‘hundreds of assets’ for paid social. Those are announced plans, rather than a verified tally of advertisements already shown or videos shared by viewers.

Outdoor advertising is planned for Los Angeles and New York. The placements include Los Angeles billboards, a Times Square subway station takeover, and advertisements inside New York subway and Long Island Rail Road cars, according to MediaPost’s interview.

A further New York promotion is scheduled to start on October 5: installations at 20 locations with 1,000 removable posters measuring 18 by 26 inches. Passers-by would be able to take posters away. Their installation and public take-up have not yet been verified.

How Fox fits Ro’s celebrity advertising strategy

Ro handles the creative work and media buying internally, MediaPost reported. Rahmanian said the target audience for Sparks centres on men in their mid-40s, and that Fox’s partnership would extend beyond the initial campaign. No firm contractual end date or fee was disclosed.

The company has also worked with Serena Williams and Charles Barkley to promote its weight-loss services. Rahmanian presented tackling stigma and working with recognisable celebrity partners as common threads across those campaigns and the Fox partnership. That precedent describes Ro’s approach; it does not establish this advertisement’s success.

What the advert does—and does not—establish

Ro’s campaign page describes Sparks as a compounded prescription product containing sildenafil and tadalafil, and states that the compounded product is not FDA-approved. The FDA explains that compounded drugs do not receive its premarket review for safety, effectiveness or quality. That is regulatory background, not a finding of wrongdoing by Ro.

The interviews establish what Fox and Ro want the campaign to do, alongside a substantial planned advertising rollout. They do not provide verified sharing totals, representative audience reactions or measured evidence of reduced stigma. The next announced steps are more television versions and the October 5 poster promotion; the campaign’s impact remains unmeasured in those reports.